Skip to content
Article Rich – Lifestyle
Author:
Ovid Therapeutics Inc.
Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14
April 8, 2026
Ovid Therapeutics Announces Pricing of $60 Million Private Placement
March 18, 2026
Ovid Therapeutics to Participate in Upcoming Investor Conferences
March 5, 2026